Addressing Unmet Needs in the Management of AML: From Testing to Targeted Therapy


EHA 2024 Insights: QuANTUM-First Trial - Newly Diagnosed FLT3-ITD+ AML Patients Receiving Chemo + Quizartinib vs. Placebo

129 views
June 28, 2024
Comments 0
Login to view comments. Click here to Login